AdNRGM

Developed for: prostate cancer
Investigated by: Department of Health, United Kingdom · Janssen, LP · Medical Research Council · University of Birmingham

today NCT04374240 · Ph 1

201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT04374240	Mar 2013 → Aug 2021	prostate cancer	University of Birmingham	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	AdNRGM	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04374240 ↗
Route	Other	“multiple, template-guided trans-perineal injections” NCT04374240 ↗